Value of Thromboelastography for Condition Assessment in Children with Mycoplasma Pneumoniae Pneumonia
1. Dalian Medical University, Dalian 116044, China 2. Department of Pediatrics, Changzhou No.2 People's Hospital, the Affiliated Hospital of Nanjing Medical University, Changzhou 213000, China 3. Nanjing Medical University, Nanjing 211166, China
GUI J J, JIN A Q, WAN Y, et al. Value of thromboelastography for condition assessment in children with mycoplasma pneumoniae pneumonia[J]. Chinese General Practice, 2022, 25 (21) : 2624-2628.
Jingjing GUI,Aquan JIN,Yu WAN, et al. Value of Thromboelastography for Condition Assessment in Children with Mycoplasma Pneumoniae Pneumonia[J]. Chinese General Practice, 2022, 25(21): 2624-2628. DOI: 10.12114/j.issn.1007-9572.2022.0002.
桂晶晶,金阿全,万瑜等. 血栓弹力图在肺炎支原体肺炎患儿病情评估中的应用价值[J]. 中国全科医学, 2022, 25(21): 2624-2628. DOI: 10.12114/j.issn.1007-9572.2022.0002.
XINGY, WANGD, SHENGK,et al. Dynamic change of Mycoplasma pneumoniae pneumonia in hospitalized children in a general hospital:a 3-year retrospective analysis[J]. Transl Pediatr,2020,9(4):522-531. DOI:10.21037/tp-20-149.
[2]
GAOL W, YINJ, HUY H,et al. The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China:2006 to 2016[J]. Epidemiol Infect,2019,147:e192. DOI:10.1017/S0950268819000839.
[3]
LIUJ W, LIY M. Thrombosis associated with Mycoplasma pneumoniae infection(Review)[J]. Exp Ther Med,2021,22(3):967. DOI:10.3892/etm.2021.10399.
LIUJ R, HER X, WUR H,et al. Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children's Hospital[J]. BMC Infect Dis,2020,20(1):51. DOI:10.1186/s12879-020-4774-9.
[7]
NARITAM. Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis[J]. Front Microbiol,2016,7:23. DOI:10.3389/fmicb.2016.00023.
[8]
KALICKIB, SADECKAM, WAWRZYNIAKA,et al. Absence of inferior vena cava in 14-year old boy associated with deep venous thrombosis and positive Mycoplasma pneumoniae serum antibodies—a case report[J]. BMC Pediatr,2015,15:40.
[9]
WITMERC M, STEENHOFFA P, SHAHS S,et al. Mycoplasma pneumoniae,splenic infarct,and transient antiphospholipid antibodies:a new association? [J]. Pediatrics,2007,119(1):e292-295. DOI:10.1542/peds.2006-1340.
PACHETA, DUMESTRE-PERARDC, MOINEM,et al. Splenic infarction associated with transient anti-prothrombin antibodies is a rare manifestation of acute Mycoplasma pneumoniae infection[J]. Arch Pediatr,2019,26(8):483-486. DOI:10.1016/j.arcped.2019.10.001.
[13]
NARITAM. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia[J]. J Infect Chemother,2010,16(3):162-169. DOI:10.1007/s10156-010-0044-x.
[14]
PODDIGHED. Mycoplasma pneumoniae-related hepatitis in children[J]. Microb Pathog,2020,139:103863. DOI:10.1016/j.micpath.2019.103863.
ZHENGY, HUAL L, ZHAOQ N,et al. The level of D-dimer is positively correlated with the severity of Mycoplasma pneumoniae pneumonia in children[J]. Front Cell Infect Microbiol,2021,11:687391. DOI:10.3389/fcimb.2021.687391.
[18]
HUANGX, LID, LIUF,et al. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia[J]. BMC Infect Dis,2021,21(1):14. DOI:10.1186/s12879-020-05700-5.
[19]
RAMADORIG. Albumin infusion in critically ill COVID-19 patients:hemodilution and anticoagulation[J]. Int J Mol Sci,2021,22(13):7126. DOI:10.3390/ijms22137126.
[20]
BRUBAKERL, MORTUSJ, CRUZM,et al. Thromboelastography might be more applicable to guide anticoagulant therapy than fibrinolytic therapy in critically ill patients with COVID-19[J]. J Am Coll Surg,2021,232(6):1021-1022. DOI:10.1016/j.jamcollsurg.2021.03.005.